The longtime president of the Ohio AFL-CIO has been summoned as a witness in a $60 million public corruption trial as lawyers work to help the former state House speaker beat charges that he was bribed in exchange for passing a nuclear plant bailout bill.

A Florida legislative committee advanced a bill that would give Republican Governor Ron DeSantis control over a special tax district that’s home to Walt Disney Co., limiting the sweeping powers granted to the entertainment giant for decades. Much of the debate centered around the decision to allow DeSantis to appoint the five-member board of supervisors overseeing what’s currently known as the Reedy Creek Improvement District.

Mercy Health and two related entities failed to convince a federal judge to let them pursue a quick appeal of an order conditionally allowing nurses to move forward with meal break pay claims as a collective.

The Australian government is facing scrutiny over its use of Big Four consultants following revelations that a former PwC partner leaked sensitive tax information.

AstraZeneca Plc is facing claims it bullied Viela Bio Inc., in which it held a 27% stake, into an underpriced $3 billion sale to another drug company to avoid potential antitrust concerns about its own $39 billion acquisition of Alexion Pharmaceuticals Inc.

The House Agriculture Committee plans to increase scrutiny of SEC climate disclosure plans that have drawn bipartisan concern that they would compel burdensome reporting from small farmers.

Bayer AG named former Roche Holding AG executive Bill Anderson to succeed Werner Baumann as chief executive officer, fueling speculation about a possible breakup of the German drug and agriculture company.